Literature DB >> 15581392

Regulation of lymphoid cell apoptosis by Jaks and Stats.

Zsuzsanna S Nagy1, Jeremy Ross, Hanyin Cheng, Stanislaw M Stepkowski, Robert A Kirken.   

Abstract

Regulation of T- and B-lymphocyte survival and death is crucial for maintaining immune homeostasis. Unresponsiveness to death signals can result in lymphoproliferative disorders including cancer and autoimmunity, whereas lymphocytes hypersensitive to such signals can be manifested as immunodeficiencies. Often within these cells, cytokines and their receptors regulate the critical balance between life and death. It is becoming ever more apparent that within these effector cascades, Janus tyrosine kinases (Jak) and signal transducers and activators of transcription (Stat) act as key regulatory components. Invaluable knowledge about Jaks and Stats has arisen from mice made genetically deficient in these mqlecules, tumor models, and proteomics/genomics, which has begun to define their role in survival versus apoptosis. These findings have also suggested how Jaks and Stats might be manipulated for therapeutic intervention in lymphoid-derived diseases. This review seeks to focus on the role of Jak tyrosine kinases and Stat transcription factors in mediating the lymphocyte life cycle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581392     DOI: 10.1615/critrevimmunol.v24.i2.10

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  3 in total

Review 1.  Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?

Authors:  Konstantinos Minas; Janet Liversidge
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

2.  STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Authors:  Zsuzsanna S Nagy; Matthew J LeBaron; Jeremy A Ross; Abhisek Mitra; Hallgeir Rui; Robert A Kirken
Journal:  Mol Cancer       Date:  2009-08-26       Impact factor: 27.401

3.  Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells.

Authors:  Zsuzsanna S Nagy; Jeremy A Ross; Georgialina Rodriguez; Balint L Balint; Lajos Szeles; Laszlo Nagy; Robert A Kirken
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.